Cross-resistance to cisplatin in cells with acquired resistance to copper

被引：0
|
作者：
Roohangiz Safaei
Kuniyuki Katano
Goli Samimi
Wiltrud Naerdemann
Jennifer L. Stevenson
Myriam Rochdi
Stephen B. Howell
机构：
[1] University of California San Diego,Department of Medicine 0058
[2] GloboMax Service Group,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2004年 / 53卷
关键词：
Copper; Cisplatin; Resistance; Transport;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：239 / 246
页数：7
相关论文
共 50 条
  • [41] Update on cross-resistance of fluoroquinolones
    Garau, J
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 94 - 98
  • [42] Reduced cisplatin uptake seen in cisplatin-resistant cells reflects a generalized uptake defect:: cross-resistance of cisplatin-resistant cells to Pseudomonas exotoxin
    Su, AW
    Shen, DW
    Chauhan, S
    Pastan, I
    Gottesman, MM
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 507A - 507A
  • [43] Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids
    Oerlemans, R
    van der Heijden, J
    Vink, J
    Dijkmans, BAC
    Kaspers, GJL
    Lems, WF
    Scheffer, GL
    Ifergan, I
    Scheper, RJ
    Cloos, J
    Assaraf, YG
    Jansen, G
    ARTHRITIS AND RHEUMATISM, 2006, 54 (02): : 557 - 568
  • [44] EXPRESSIONS OF RESISTANCE AND CROSS-RESISTANCE IN TENIPOSIDE-RESISTANT L1210 CELLS
    ROBERTS, D
    LEE, T
    PARGANAS, E
    WIGGINS, L
    YALOWICH, J
    ASHMUN, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 19 (02) : 123 - 130
  • [45] Mutation Landscape of Acquired Cross-Resistance to Glycopeptide and β-Lactam Antibiotics in Enterococcus faecium
    Sacco, Emmanuelle
    Cortes, Melanie
    Josseaume, Nathalie
    Bouchier, Christiane
    Dubee, Vincent
    Hugonnet, Jean-Emmanuel
    Mainardi, Jean-Luc
    Rice, Louis B.
    Arthur, Michel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) : 5306 - 5315
  • [46] CROSS-RESISTANCE TO DIVERSE DRUGS IS ASSOCIATED WITH PRIMARY CISPLATIN RESISTANCE IN OVARIAN-CANCER CELL-LINES
    HAMAGUCHI, K
    GODWIN, AK
    YAKUSHIJI, M
    ODWYER, PJ
    OZOLS, RF
    HAMILTON, TC
    CANCER RESEARCH, 1993, 53 (21) : 5225 - 5232
  • [47] Cross-Resistance of Acquired Radioresistant Colorectal Cancer Cell Line to gefitinib and regorafenib
    Afshar, Saeid
    Pashaki, Abdolazim Sedighi
    Najafi, Rezvan
    Nikzad, Safoora
    Amini, Razieh
    Shabab, Nooshin
    Khiabanchian, Omid
    Tanzadehpanah, Hamid
    Saidijam, Massoud
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2020, 45 (01) : 50 - 58
  • [48] EXPRESSION OF RESISTANCE AND CROSS-RESISTANCE IN DIAZIQUONE (AZQ) RESISTANT P388 CELLS
    GUTIERREZ, PL
    SHAPIRO, W
    MILLER, B
    BISWAL, N
    ROSS, K
    DOROSHOW, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 318 - 318
  • [49] Molecular mechanisms of acquired cisplatin resistance in urothelial carcinoma cells
    Hoehn, A.
    Krueger, K.
    Skowron, M.
    Fritz, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S70 - S70
  • [50] Influence of p53 on the role of mismatch repair in cisplatin resistance and cross-resistance to other antitumor agents.
    Sumiyoshi, Y
    Ojima, H
    Mujoo, K
    Kondo, Y
    Shen, L
    Issa, JPJ
    Ghosh, S
    Farquhar, D
    Khokhar, AR
    Siddik, ZH
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6073S - 6073S
12345